Avalon Ventures IX, L.P.

All filings by Avalon Ventures IX, L.P. on record concern Aratana Therapeutics, Inc. Between 2 July 2013 and 3 February 2014, the trades on record add up to 8 filings.

Both buying and selling appear: 1 purchase worth €2.3M, against 1 sale worth €11.6M. Taken together, the sales exceed the purchases by €9.3M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. In 2014 alone, the filings show no purchases and 1 sale.

Most recently, on 5 February 2014, the filings show an open-market sale worth €11.6M in Aratana Therapeutics, Inc. The last insider purchase was made public on 8 July 2013, 4,872 days ago. Filings reach the SEC (Form 4) feed a median of 5 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.